Cargando…

Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise

Urocortin3 (UCN3) regulates metabolic functions and is involved in cellular stress response. Although UCN3 is expressed in human adipose tissue, the association of UCN3 with obesity and diabetes remains unclear. This study investigated the effects of Type 2 diabetes (T2D) and increased body weight o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavalakatt, Sina, Khadir, Abdelkrim, Madhu, Dhanya, Hammad, Maha, Devarajan, Sriraman, Abubaker, Jehad, Al-Mulla, Fahd, Tuomilehto, Jaakko, Tiss, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851015/
https://www.ncbi.nlm.nih.gov/pubmed/31781037
http://dx.doi.org/10.3389/fendo.2019.00762
_version_ 1783469548714852352
author Kavalakatt, Sina
Khadir, Abdelkrim
Madhu, Dhanya
Hammad, Maha
Devarajan, Sriraman
Abubaker, Jehad
Al-Mulla, Fahd
Tuomilehto, Jaakko
Tiss, Ali
author_facet Kavalakatt, Sina
Khadir, Abdelkrim
Madhu, Dhanya
Hammad, Maha
Devarajan, Sriraman
Abubaker, Jehad
Al-Mulla, Fahd
Tuomilehto, Jaakko
Tiss, Ali
author_sort Kavalakatt, Sina
collection PubMed
description Urocortin3 (UCN3) regulates metabolic functions and is involved in cellular stress response. Although UCN3 is expressed in human adipose tissue, the association of UCN3 with obesity and diabetes remains unclear. This study investigated the effects of Type 2 diabetes (T2D) and increased body weight on the circulatory and subcutaneous adipose tissue (SAT) levels of UCN3 and assessed UCN3 modulation by a regular physical exercise. Normal-weight (n = 37) and overweight adults with and without T2D (n = 98 and n = 107, respectively) were enrolled in the study. A subset of the overweight subjects (n = 39 for each group) underwent a supervised 3-month exercise program combining both moderate intensity aerobic exercise and resistance training with treadmill. UCN3 levels in SAT were measured by immunofluorescence and RT-PCR. Circulatory UCN3 in plasma was assessed by ELISA and was correlated with various clinical and metabolic markers. Our data revealed that plasma UCN3 levels decreased in overweight subjects without T2D compared with normal-weight controls [median; 11.99 (0.78–86.07) and 6.27 (0.64–77.04), respectively; p < 0.001], whereas plasma UCN3 levels increased with concomitant T2D [median; 9.03 (0.77–104.92) p < 0.001]. UCN3 plasma levels were independently associated with glycemic index; fasting plasma glucose and hemoglobin A1c (r = 0.16 and r = 0.20, p < 0.05, respectively) and were significantly different between both overweight, with and without T2D, and normal-weight individuals (OR = 2.11 [1.84–4.11, 95% CI] and OR = 2.12 [1.59–3.10, 95% CI], p < 0.01, respectively). Conversely, the UCN3 patterns observed in SAT were opposite to those in circulation; UCN3 levels were significantly increased with body weight and decreased with T2D. After a 3-month supervised exercise protocol, UCN3 expression showed a significant reduction in SAT of both overweight groups (2.3 and 1.6-fold change; p < 0.01, respectively). In conclusion, UCN levels are differentially dysregulated in obesity in a tissue-dependent manner and can be mitigated by regular moderate physical exercise.
format Online
Article
Text
id pubmed-6851015
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68510152019-11-28 Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise Kavalakatt, Sina Khadir, Abdelkrim Madhu, Dhanya Hammad, Maha Devarajan, Sriraman Abubaker, Jehad Al-Mulla, Fahd Tuomilehto, Jaakko Tiss, Ali Front Endocrinol (Lausanne) Endocrinology Urocortin3 (UCN3) regulates metabolic functions and is involved in cellular stress response. Although UCN3 is expressed in human adipose tissue, the association of UCN3 with obesity and diabetes remains unclear. This study investigated the effects of Type 2 diabetes (T2D) and increased body weight on the circulatory and subcutaneous adipose tissue (SAT) levels of UCN3 and assessed UCN3 modulation by a regular physical exercise. Normal-weight (n = 37) and overweight adults with and without T2D (n = 98 and n = 107, respectively) were enrolled in the study. A subset of the overweight subjects (n = 39 for each group) underwent a supervised 3-month exercise program combining both moderate intensity aerobic exercise and resistance training with treadmill. UCN3 levels in SAT were measured by immunofluorescence and RT-PCR. Circulatory UCN3 in plasma was assessed by ELISA and was correlated with various clinical and metabolic markers. Our data revealed that plasma UCN3 levels decreased in overweight subjects without T2D compared with normal-weight controls [median; 11.99 (0.78–86.07) and 6.27 (0.64–77.04), respectively; p < 0.001], whereas plasma UCN3 levels increased with concomitant T2D [median; 9.03 (0.77–104.92) p < 0.001]. UCN3 plasma levels were independently associated with glycemic index; fasting plasma glucose and hemoglobin A1c (r = 0.16 and r = 0.20, p < 0.05, respectively) and were significantly different between both overweight, with and without T2D, and normal-weight individuals (OR = 2.11 [1.84–4.11, 95% CI] and OR = 2.12 [1.59–3.10, 95% CI], p < 0.01, respectively). Conversely, the UCN3 patterns observed in SAT were opposite to those in circulation; UCN3 levels were significantly increased with body weight and decreased with T2D. After a 3-month supervised exercise protocol, UCN3 expression showed a significant reduction in SAT of both overweight groups (2.3 and 1.6-fold change; p < 0.01, respectively). In conclusion, UCN levels are differentially dysregulated in obesity in a tissue-dependent manner and can be mitigated by regular moderate physical exercise. Frontiers Media S.A. 2019-11-06 /pmc/articles/PMC6851015/ /pubmed/31781037 http://dx.doi.org/10.3389/fendo.2019.00762 Text en Copyright © 2019 Kavalakatt, Khadir, Madhu, Hammad, Devarajan, Abubaker, Al-Mulla, Tuomilehto and Tiss. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Kavalakatt, Sina
Khadir, Abdelkrim
Madhu, Dhanya
Hammad, Maha
Devarajan, Sriraman
Abubaker, Jehad
Al-Mulla, Fahd
Tuomilehto, Jaakko
Tiss, Ali
Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise
title Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise
title_full Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise
title_fullStr Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise
title_full_unstemmed Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise
title_short Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise
title_sort urocortin 3 levels are impaired in overweight humans with and without type 2 diabetes and modulated by exercise
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851015/
https://www.ncbi.nlm.nih.gov/pubmed/31781037
http://dx.doi.org/10.3389/fendo.2019.00762
work_keys_str_mv AT kavalakattsina urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise
AT khadirabdelkrim urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise
AT madhudhanya urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise
AT hammadmaha urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise
AT devarajansriraman urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise
AT abubakerjehad urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise
AT almullafahd urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise
AT tuomilehtojaakko urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise
AT tissali urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise